Pyrrolidine sulfonamides
    35.
    发明授权
    Pyrrolidine sulfonamides 失效
    吡咯烷磺酰胺

    公开(公告)号:US07019008B2

    公开(公告)日:2006-03-28

    申请号:US11119026

    申请日:2005-04-29

    IPC分类号: A61K31/496 C07D409/14

    CPC分类号: C07D409/12

    摘要: A compound of Formula (I): wherein: R1 is C1-6 alkyl, benzyl, or (CH2)n—C(O)NH2; wherein the benzyl may be unsubstituted or substituted by one or two C1-6 alkyl, halogen, C1-6 alkoxy, or methylenedioxy groups; R2 is benzimidazolyl, quinolinyl, benzofuranyl, napthyl, indolyl, benzothiophenyl, phenyl, furanyl, thienyl, or pyridyl substituted or unsubstituted by one, two or three halogen, C1-3 alkyl, C1-3 alkoxy, or methylenedioxy groups; X1 and X2 are independently hydrogen, halogen, C1-3 alkyl, C1-3 alkoxy, nitro, CF3, or CN; n is 1, 2, or 3; m is 1, 2 or 3; or a pharmaceutically acceptable salt thereof.

    摘要翻译: 式(I)的化合物:其中:R 1是C 1-6烷基,苄基或(CH 2 CH 2) -C(O)NH 2; 其中苄基可以是未取代的或被一个或两个C 1-6烷基,卤素,C 1-6烷氧基或亚甲二氧基取代; R 2是苯并咪唑基,喹啉基,苯并呋喃基,萘基,吲哚基,苯并噻吩基,苯基,呋喃基,噻吩基或被1,2或3个卤素取代或未取代的吡啶基, 亚烷基,C 1-3烷氧基或亚甲二氧基; X 1和X 2独立地是氢,卤素,C 1-3烷基,C 1-3烷氧基 ,硝基,CF 3或CN; n为1,2或3; m为1,2或3; 或其药学上可接受的盐。